Michio Mito, MD, PhD | Authors

UFT and Mitomycin Plus Tamoxifen for Stage II, ER-Positive Breast Cancer

July 01, 1999

A trial was designed to examine the combination of UFT and mitomycin (Mutamycin) plus tamoxifen (Nolvadex) as postoperative adjuvant therapy in the treatment of patients with stage II, estrogen receptor (ER)-positive